T1	intervention 26 34	Exercise
T2	duration 661 668	12-week
T3	eligibility 794 816	Breast cancer patients
T4	control 893 917	relaxation control group
T5	No-of-participants 969 971	19
T6	outcome 1230 1260	higher differential expression
T7	outcome 1484 1507	gene expression profile
